Northside Capital Management LLC Decreases Stake in Citigroup Inc. $C

Northside Capital Management LLC cut its position in shares of Citigroup Inc. (NYSE:C) by 28.4% in the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 85,841 shares of the company’s stock after selling 34,091 shares during the period. Northside Capital Management LLC’s holdings in Citigroup were worth $12,014,000 as of its most recent SEC filing.

A number of other large investors have also added to or reduced their stakes in C. Cora Capital Advisors LLC boosted its position in shares of Citigroup by 3.1% during the 1st quarter. Cora Capital Advisors LLC now owns 2,609 shares of the company’s stock valued at $296,000 after acquiring an additional 78 shares during the last quarter. CFS Investment Advisory Services LLC grew its stake in shares of Citigroup by 0.4% in the 1st quarter. CFS Investment Advisory Services LLC now owns 20,596 shares of the company’s stock worth $2,336,000 after buying an additional 79 shares in the last quarter. Verus Capital Partners LLC grew its stake in shares of Citigroup by 3.1% in the 4th quarter. Verus Capital Partners LLC now owns 2,748 shares of the company’s stock worth $321,000 after buying an additional 82 shares in the last quarter. Somerset Trust Co increased its holdings in shares of Citigroup by 0.6% in the 2nd quarter. Somerset Trust Co now owns 14,955 shares of the company’s stock worth $2,093,000 after buying an additional 82 shares during the last quarter. Finally, CFO Capital Management LLC increased its holdings in shares of Citigroup by 1.5% in the 1st quarter. CFO Capital Management LLC now owns 5,495 shares of the company’s stock worth $590,000 after buying an additional 83 shares during the last quarter. Institutional investors own 71.72% of the company’s stock.

Citigroup News Summary

Here are the key news stories impacting Citigroup this week:

• Positive Sentiment: Citi strengthens healthcare investment-banking leadership. Citigroup appointed new leaders covering biotechnology, medical technology, biopharmaceuticals and acute care, positioning the bank to capture potential dealmaking as healthcare mergers, acquisitions and financing activity accelerates. The move could support future advisory and underwriting revenue. Citi Taps New Healthcare Banking Leadership as Dealmaking Heats Up
• Positive Sentiment: Citi helped lead a $414 million financing for inKind. The oversubscribed transaction, led by Citigroup and Cross River, expands Citi’s relationships with private companies and demonstrates continued demand for its lending and capital-markets services. The financial impact was not disclosed, so the direct earnings benefit is likely limited in the near term. inKind Secures $414 Million in Financing Led by Citi and Cross River
• Neutral Sentiment: Citi remains constructive on MongoDB. The bank reiterated a Buy rating and raised its MongoDB price target to $545, citing possible estimate increases, earnings, product announcements and investor events. This reflects Citi’s research outlook rather than a direct catalyst for Citigroup’s own earnings, though successful client coverage and research visibility can support institutional relationships. Citi bullish on MongoDB stock

Citigroup Price Performance

Citigroup stock opened at $135.78 on Wednesday. Citigroup Inc. has a 12-month low of $90.68 and a 12-month high of $147.96. The company has a current ratio of 0.99, a quick ratio of 0.99 and a debt-to-equity ratio of 1.71. The firm has a 50-day moving average price of $137.02 and a 200-day moving average price of $125.19. The firm has a market capitalization of $231.58 billion, a PE ratio of 14.66, a price-to-earnings-growth ratio of 0.61 and a beta of 1.12.

Citigroup (NYSE:C) last issued its quarterly earnings results on Tuesday, July 14th. The company reported $3.15 EPS for the quarter, beating the consensus estimate of $2.74 by $0.41. Citigroup had a net margin of 10.23% and a return on equity of 10.15%. The company had revenue of $24.77 billion for the quarter, compared to the consensus estimate of $23.74 billion. During the same period in the prior year, the firm posted $1.96 EPS. The firm’s revenue was up 14.5% compared to the same quarter last year. As a group, equities research analysts forecast that Citigroup Inc. will post 11.2 EPS for the current year.

Citigroup declared that its board has initiated a share buyback plan on Thursday, May 7th that allows the company to buyback $30.00 billion in shares. This buyback authorization allows the company to buy up to 13.7% of its stock through open market purchases. Stock buyback plans are generally an indication that the company’s leadership believes its shares are undervalued.

Citigroup Increases Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, August 28th. Stockholders of record on Monday, August 3rd will be paid a dividend of $0.67 per share. This is a positive change from Citigroup’s previous quarterly dividend of $0.60. This represents a $2.68 dividend on an annualized basis and a dividend yield of 2.0%. The ex-dividend date of this dividend is Monday, August 3rd. Citigroup’s payout ratio is currently 28.94%.

Analysts Set New Price Targets

A number of research analysts recently commented on the stock. Evercore set a $143.00 price target on shares of Citigroup in a report on Monday, July 6th. Wells Fargo & Company boosted their price objective on Citigroup from $162.00 to $165.00 and gave the stock an “overweight” rating in a research note on Thursday, June 18th. Piper Sandler restated an “overweight” rating and set a $145.00 price objective (up from $125.00) on shares of Citigroup in a research report on Wednesday, April 15th. Weiss Ratings restated a “buy (b)” rating on shares of Citigroup in a research report on Friday, July 17th. Finally, Morgan Stanley raised their price objective on Citigroup from $154.00 to $164.00 and gave the company an “overweight” rating in a research note on Monday, June 29th. Two investment analysts have rated the stock with a Strong Buy rating, thirteen have assigned a Buy rating and four have assigned a Hold rating to the company’s stock. According to data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $145.22.

Citigroup Company Profile

Citigroup Inc is a global financial services company headquartered in New York City with roots tracing back to the City Bank of New York, founded in 1812. The modern Citigroup was created through the 1998 merger of Citicorp and Travelers Group and has since operated as a diversified bank holding company that provides a broad range of banking and financial products and services to consumers, corporations, governments and institutions worldwide.

Citi’s principal businesses include retail and commercial banking, credit card and consumer lending products, wealth management and private banking, and a full suite of institutional services.